Predictions
Enlivex Therapeutics Ltd.
Start price
Target price
Perf. (%)
€1.51
13.04.24
13.04.24
€2.00
13.04.25
13.04.25
-0.66%
27.04.24
27.04.24
negative Cash Flow expected
Few uniques
Growths slower than the competition
Below average Marketposition
Enlivex Therapeutics Ltd.
Start price
Target price
Perf. (%)
€1.72
11.04.24
11.04.24
-
11.04.25
11.04.25
-12.21%
14.04.24
14.04.24
Could be worthwhile Investment >10% per year
Deutsche Pfandbriefbank AG
Start price
Target price
Perf. (%)
€5.06
09.04.24
09.04.24
€5.00
09.04.25
09.04.25
13.24%
18.05.24
18.05.24
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Undervalued
Plug Power Inc.
Start price
Target price
Perf. (%)
€2.91
08.04.24
08.04.24
€3.00
08.04.25
08.04.25
-21.66%
27.04.24
27.04.24
Good rating
Revenue growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€66.50
07.04.24
07.04.24
-
07.04.25
07.04.25
0.75%
14.04.24
14.04.24
Could be very worthwhile Investment >20% year
Insmed Inc.
Start price
Target price
Perf. (%)
€25.40
07.04.24
07.04.24
€15.00
30.09.25
30.09.25
-7.09%
13.05.24
13.05.24
Could be very worthwhile Investment >20% year
AT&S Austria Technologie & Systemtechnik AG
Start price
Target price
Perf. (%)
€19.31
04.04.24
04.04.24
€26.00
04.04.25
04.04.25
-1.61%
13.04.24
13.04.24
Hypoport SE
Start price
Target price
Perf. (%)
€235.20
02.04.24
02.04.24
€166.00
02.04.25
02.04.25
-4.76%
13.04.24
13.04.24
Probably not worthwhile Investment
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
High valuation
Deutsche Pfandbriefbank AG
Start price
Target price
Perf. (%)
€4.81
27.03.24
27.03.24
€5.00
27.03.25
27.03.25
5.24%
09.04.24
09.04.24
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Undervalued
Akebia Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.88
26.03.24
26.03.24
-
26.03.25
26.03.25
-18.09%
31.03.24
31.03.24
Risky Investment
Hypoport SE
Start price
Target price
Perf. (%)
€239.60
22.03.24
22.03.24
-
22.03.25
22.03.25
13.11%
06.05.24
06.05.24
Very low/no dividend yield expected
EBIT decline/stagnation expected
SMA Solar Technology AG
Start price
Target price
Perf. (%)
€55.00
22.03.24
22.03.24
-
22.04.24
22.04.24
-13.27%
23.04.24
23.04.24
Could be worthwhile Investment >10% per year
Marathon Digital Holdings
Start price
Target price
Perf. (%)
€16.94
19.03.24
19.03.24
€22.00
19.03.25
19.03.25
14.24%
30.03.24
30.03.24
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Some uniques
Risky balance sheet
Super Micro Computer
Start price
Target price
Perf. (%)
€828.60
19.03.24
19.03.24
€900.00
19.03.25
19.03.25
18.14%
30.03.24
30.03.24
Could be very worthwhile Investment >20% year
Higher EBIT margin than peer group
Capable Management
Low dividend yield expected
Super Micro Computer
Start price
Target price
Perf. (%)
€973.00
18.03.24
18.03.24
€666.00
18.03.25
18.03.25
0.61%
30.03.24
30.03.24
Probably not worthwhile Investment
High valuation
Low dividend yield expected
negative Cash Flow expected
ABC Arbitrage S.A.
Start price
Target price
Perf. (%)
€3.85
18.03.24
18.03.24
-
18.03.25
18.03.25
2.47%
30.03.24
30.03.24
Could be worthwhile Investment >10% per year
Akebia Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.51
18.03.24
18.03.24
-
18.03.25
18.03.25
2.26%
30.03.24
30.03.24
Could be worthwhile Investment >10% per year
Akebia Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.51
17.03.24
17.03.24
€0.30
30.11.25
30.11.25
76.96%
28.03.24
28.03.24
Could be very worthwhile Investment >20% year
Inventiva SA
Start price
Target price
Perf. (%)
€3.71
17.03.24
17.03.24
€5.00
31.01.26
31.01.26
-2.70%
19.03.24
19.03.24
Could be very worthwhile Investment >20% year
Verastem Inc.
Start price
Target price
Perf. (%)
€10.20
17.03.24
17.03.24
€16.00
30.06.26
30.06.26
-8.82%
19.03.24
19.03.24
Could be very worthwhile Investment >20% year
Akebia Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.51
16.03.24
16.03.24
€2.00
16.03.25
16.03.25
2.26%
30.03.24
30.03.24
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Low dividend yield expected
Chromadex Corp
Start price
Target price
Perf. (%)
€2.22
16.03.24
16.03.24
€4.00
16.03.25
16.03.25
53.15%
30.03.24
30.03.24
EBIT decline/stagnation expected
Revenue decline/stagnation expected
High valuation
Low dividend yield expected
Novavax Inc.
Start price
Target price
Perf. (%)
€4.89
16.03.24
16.03.24
€48.00
16.03.25
16.03.25
-12.06%
30.03.24
30.03.24
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Rising EBIT margin expected
Low dividend yield expected